title: Include discussions and review of systems regarding inflammatory bowel disease in patients starting isotretinoin therapy: comment on "Isotretinoin therapy and inflammatory bowel disease".
authors.affiliation: Division of Internal Medicine, Dermatology Section and Dermatology, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, Case Western Reserve College of Medicine, 157 W Cedar St, Ste 101, Akron, OH 44307, USA. emostow@neoucom.edu
authors.forename: Eliot N
authors.initials: EN
authors.lastname: Mostow
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000139:chemically induced*; D015474:Isotretinoin / Q000009:adverse effects* / Q000627:therapeutic use; D016365:Liability, Legal
chemical_list: D003879:Dermatologic Agents; D015474:Isotretinoin